Heron Therapeutics
HRTX
$2.49
Share price
1.63%
Change (1 day)
4.18%
Change (1 year)
Categories
Heron Therapeutics (HRTX) - P/B ratio
P/B ratio as of April 2024 : -10.8
According to Heron Therapeutics's latest financial reports the company has a price-to-book ratio of -10.8.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Heron Therapeutics - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -7.51 | -134.29% |
| 2022-12-31 | 21.9 | 82.53% |
| 2021-12-31 | 12.0 | 46.82% |
| 2020-12-31 | 8.17 | 55.51% |
| 2019-12-31 | 5.25 | -4.08% |
| 2018-12-31 | 5.48 | -38.16% |
| 2017-12-31 | 8.86 | -136.67% |
| 2016-12-31 | -24.2 | -395.96% |
| 2015-12-31 | 8.16 | 75.06% |
| 2014-12-31 | 4.66 | 53.23% |
| 2013-12-31 | 3.04 | -4.27% |
| 2012-12-31 | 3.18 | 8.84% |
| 2011-12-31 | 2.92 | -78.78% |
| 2010-12-31 | 13.8 | 85.89% |
| 2009-12-31 | 7.40 | 332.9% |
| 2008-12-31 | 1.71 | 3.62% |
| 2007-12-31 | 1.65 | -42.89% |
| 2006-12-31 | 2.89 | -53.65% |
| 2005-12-31 | 6.24 | 113.66% |
| 2004-12-31 | 2.92 | -35.01% |
| 2003-12-31 | 4.49 | 239.14% |
| 2002-12-31 | 1.32 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | 3.05 | -128.13% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | 1.41 | -112.99% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | 1.78 | -116.44% | 🇺🇸 USA |
 Alkermes ALKS | 3.47 | -132.02% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | 1.85 | -117.07% | 🇺🇸 USA |